Exemestane With or Without Bicalutamide in Treating Patients With Stage IV Prostate Cancer

NCT00031889 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Exemestane
DRUG: Exemestane+bicalutamide

Sponsor

Swiss Cancer Institute